Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

The coronavirus disease 2019 (COVID-19) pandemic was a cataclysmic event that infected over 772 million and killed over 6.9 million people worldwide. The pandemic pushed hospitals and society to their limits and resulted in incredibly severe respiratory disease in millions of people. This severe res...

Full description

Saved in:
Bibliographic Details
Published inAdvances in surgery (Chicago) Vol. 58; no. 1; pp. 249 - 273
Main Authors Ruck, Jessica M., Bush, Errol L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2024
Subjects
Cardiac failure
Coronavirus
COVID-19
COVID-19 - epidemiology
COVID-19 - therapy
Extracorporeal Membrane Oxygenation
Humans
Pandemics
Respiratory failure
SARS-CoV-2
VV ECMO
COVID-19
Cardiac failure
Extracorporeal membrane oxygenation
Coronavirus
Respiratory failure
VV ECMO
Online AccessGet full text

Cover

More Information
Summary:The coronavirus disease 2019 (COVID-19) pandemic was a cataclysmic event that infected over 772 million and killed over 6.9 million people worldwide. The pandemic pushed hospitals and society to their limits and resulted in incredibly severe respiratory disease in millions of people. This severe respiratory disease often necessitated maximum medical therapy, including the use of extracorporeal membrane oxygenation. While our understanding of COVID-19 and its treatment continue to evolve, we review the current evidence to guide the care of patients with severe COVID-19 infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0065-3411
1878-0555
1878-0555
DOI:10.1016/j.yasu.2024.05.003